Inhibition of N-methyl-D-aspartate receptors by haloperidol: Developmental and pharmacological characterization in native and recombinant receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 154-161

  Lynch, David R ^a   Gallagher, Michael J ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DITOLYLGUANIDINE; DIZOCILPINE; HALOPERIDOL; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; SPERMIDINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; HUMAN; HUMAN CELL; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; ANTIPSYCHOTIC AGENTS; DIZOCILPINE MALEATE; HALOPERIDOL; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA; RECOMBINANT PROTEINS; SPERMIDINE;

EID: 0030425689     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. ANEGAWA, N. J., LYNCH, D. R., VERDOORN, T. A. AND PRITCHETT, D. B.: Transfection of N-methyl-S-aspartate receptors in a nonneuronal cell line leads to cell death. J. Neurochem. 64: 2004-2012, 1995.
2. 3H]dopamine binding associated with dopamine receptors in calf brain membranes. Mol. Pharmacol. 12: 800-812, 1976.
3. CHAZOT, P. L., COLEMAN, S. K., CIK, M. AND STEPHENSON, F. A.: Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J. Biol. Chem. 269: 24403-24409, 1994.
4. CHEN, C. AND OKAYAMA H.: High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745-2752, 1987.
5. CHOI, D.: Calcium mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci. 7: 357-368, 1988.
6. CHURCH, J., SAWYER, D. AND MCLARNON, J. G.: Interactions of dextromethorphan with the N-methyl-D-aspartate receptor-channel complex: Single channel recordings. Brain Res. 666: 189-194, 1994.
7. COLLINGRIDGE, G. L. AND LESTER, R. A. J.: Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 41: 143-210, 1989.
8. DAHL, S. G.: Plasma level monitoring of antipsychotic drugs: clinical utility. Clin. Pharmacokinet. 11: 36-61, 1986.
9. 3H]ifenprodil binding sites in the rat brain. Neurosci. Lett. 125: 45-48, 1991.
10. DECOSTER, M. A., KLETTE, K. L., KNIGHT, E. S. AND TORTELLA, F. C.: Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 671: 45-53, 1995.
11. DOWNES, C. P., LEWIS, P. E. AND STONE, M. A.: Comparison of the binding of sigma opioids and phencyclidine, and the interaction with antipsychotic drugs in rat brain membranes. Clin. Pharmacol. 88: 231-237, 1986.
12. DURAND, G. M., BENNETT, M. V. AND ZUKIN R. S.: Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 90: 6731-6735, 1993.
13. FERRIS, C. D., HIRSCH, D. J., BROOKS, B. P. AND SNYDER, S. H.: Sigma receptors: From molecule to man. J. Neurochem. 57: 729-737, 1991.
14. FLETCHER, E. J. AND MACDONALD, J. F.: Haloperidol interacts with the strych-nine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. Eur J. Pharmacol. 235: 291-295, 1993.
15. FLETCHER, E. J., CHURCH, H., ABDELHAMID, K. AND MACDONALD, J. F.: Blockade by sigma site ligands of N-methyl-D-aspartate evoked responses in rat and mouse cultured hippocampal pyramidal neurons. Br. J. Pharmacol. 116: 2791-2800, 1995.
16. FROEMMING, J. S., LAM, Y. W., JANN, M. W. AND DAVIS, C. W.: Pharmacokinetics of haloperidol. Clin. Pharmacokinet. 17: 396-423, 1989.
17. GALLAGHER, M. J., PRITCHETT, D. L., HUANG, H. AND LYNCH, D. R.: Interaction between ifenprodil and the NR 2B subunit of the N-methyl-D-aspartate receptor. B. Biol. Chem. 271: 9603-9611, 1996.
18. HAYASHI, T., KAGAYA, A., TAKEBAYASHI, M., SHIMUZU, M., UCHITOMI, Y., MOTOHASHI, N. AND YAMAWAKI S.: Modulation by sigma-ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons. J. Pharmacol. Exp. Ther. 275: 207-214, 1995.
19. HOLLMANN, M., BOULTER, J., MARON, C., BEASLEY, L., SULLIVAN, J., PECHT, G. AND HEINEMANN, S.: Zinc potentiates agonist induced currents at certain splice variants of the NMDA receptor. Neuron 10: 943-954, 1993.
20. ILYIN, V., GUASTELLA, J., CAI, S. X., WEBER, E. AND WOODWARD, R. M.: Subunit selective inhibition of cloned NMDA receptors by haloperidol. Soc. Neurosci. Abstr. 20: 1143, 1995.
21. ISHII, T., MORIYOSHI, K., SUGIHARA, H., SAKURADA, K., KADOTANI, H., YOKOI, M., AKAZAWA, C., SHIGEMOTO R., MIZUNO, N., MASU M. AND NAKANISHI S.: Molecular characterization of a family of N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268: 2836-2843, 1993.
22. JAVITCH, J. A., LI, X., KABACK, J. AND KARLIN, A.: A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice. Proc. Natl. Acad. Sci. U.S.A. 91: 10355-10359, 1994.
23. KLEIN, M., COOPER, T. B. AND MUSACCHIO J. M.: Effects of haloperidol and reduced haloperidol on binding to sigma sites. Eur. J. Pharmacol. 254: 239-248, 1994.
24. 3H-1-[1-(2-thienyl)cyclohexyl}piperidine. J. Pharmacol Exp. Ther. 238: 739-747, 1986.
25. LARGENT, B. L., WIKSTROM H., GUNDLACH A. L. AND SNYDER S. H.: Structural determinants of sigma receptor affinity. Mol. Pharmacol. 32: 772-784, 1987.
26. LAURIE, D. J. AND SEEBURG, P. H.: Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Mol. Pharmacol. 268: 335-345, 1994.
27. LEGENDRE, O. AND WESTBROOK, G. L.: Ifenprodil blocks N-methyl-D-aspartate receptors by a two component mechanism. Mol. Pharmacol. 40: 289-298, 1991.
28. LOVINGER, D. M.: Developmental decrease in ethanol inhibition of N-methyl-D-aspartate receptors in rat neocortical neurons: Relation to the actions of ifenprodil. J. Pharmacol. Exp. Ther. 274: 164-72, 1995.
29. LYNCH, D. R., ANEGAWA, N. J., VERDOORN, T. AND PRITCHETT, D. B.: N-methyl-D-aspartate receptors: Different subunit requirement for binding of glutamate antagonists, glycine antagonists and channel blocking agents. Mol. Pharmacol. 45: 540-545, 1994.
30. LYNCH D. R., LAWRENCE J. J., LENZ S., ANEGAWA N. J., DICHTER M. AND PRITCHETT, D. B.: Pharmacological Characterization of heterodimeric NMDA receptors composed of NR 1a and 2B subunits: Differences with receptors formed from NR 1a and 2A. J. Neurochem. 64: 1462-1468, 1995.
31. MEGURO, H., MORI, H., ARAKI, K., KUSHIYA, E., KUTSUWADA, T., YAMAZAKI, M., KUMANISHI, T., ARAKAWA M., SAKIMURA, K. AND MISHINA, M.: Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNA's. Nature 357: 70-74, 1992.
32. MONYER, H., BURNASHEV, N., LAURIE, D. J., SAKMANN, B. AND SEEBURG, P. H.: Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529-540, 1994.
33. MONYER, H., SPRENGEL, R., SCHOEPFER, R., HERB, A., HIGUCHI, M., LOMELI, H., BURNASHEV, N., SAKMANN B. AND SEEBURG, P. H.: Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science 256: 1217-1221, 1992.
34. MONAGHAN, D. T., OLVERMAN, H. J., NGUYEN, L., WATKINS, J. C., AND COTMAN, C. W.: Two classes of N-methyl-D-aspartate recognition sites: Differential distribution and differential regulation by glycine. Proc. Natl. Acad. Sci. U.S.A. 85: 9836-9840, 1988.
35. MOOR, M. J., STEINER, S. H., JACHERTZ, G. AND BICKEL, M. H.: Adipose tissue distribution and chemical strucutre of lipophilic drugs: Desipramine, N-acetyl-desipramine and haloperidol. Pharmacol. Toxicol. 70: 121-124, 1992.
36. PARK, K. H., LEE, M. H. AND LEE, M. G.: Simultaneous determination of haloperidol and its metabolite, reduced haloperidol, in plasma, blood, urine, and tissue homogenstes by high performance liquid chromatography. J. Chromatog. 572: 259-267, 1991.
37. 125I-iododizocilpine binding to the N-methyl-D-aspartate receptor of rat brain membranes. J. Neurochem. 58: 1469-1476, 1992.
38. REYNOLDS, I. J. AND MILLER, R. J.: Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: Interaction with polyamines. Mol. Pharmacol. 36: 758-765, 1989.
39. ROCK, D. M. AND MACDONALD, R. L.: The polyamine spermine has multiple actions on N-methyl-D-aspartate receptor single-channel currents in cultured cortical neurons. Mol. Pharmacol. 41: 83-88, 1992.
40. 3H]-1,3-Di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: Evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands. Mol. Pharmacol. 39: 222-232, 1991.
41. SCHERZ, M. W., FIALEIX, M., FISCHER, J. B., REDDY, N. L., SERVER, A. C., SONDERS, M. S., TESTER, B. C., WEBER, E., WONG, S. T. AND KEANA, J. F.W.: Synthesis and structure activity relationships of N, N′-Di-O-tolylguanidine analogues, high affinity ligands for the haloperidol-sensitive sigma receptor. J. Med. Chem. 33: 2421-2429, 1990.
42. SUGIHARA, H., MORIYOSHI, K., ISHII, T., MASU, M. AND NAKANISHI, S.: Structure and properties of 7 isoforms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Commun. 185: 826-832, 1992.
43. VICINI, S., WANG, J. F., POLING, J. S., AND GRAYSON, D. R.: Functional and pharmacological differences between recombinant and native NMDA receptors. Soc. Neurosci. Abstr. 21: 86, 1995.
44. WATANABE, M., INOUE, Y., SAKIMURA K. AND MISHINA, M.: Developmental changes in distribution of NMDA receptor channel subunit mRNA's. NeuroReport 3: 1138-1140, 1992.
45. WILLIAMS, K.: Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor Selectivity and mechanism at recombinant heteromeric receptors. Mol. Pharmacol. 44: 851-859, 1993.
46. WILLIAMS, K. C., HANNA, J., AND MOLINOFF, P. B.: Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines. Mol. Pharmacol. 40: 774-782, 1991a.
47. WILLIAMS, K. A., ROMANO, C., DICHTER, M. A. AND MOLINOFF, P. B.: Minireview: Modulation of the NMDA receptor by polyamines. Life Sci. 48: 469-498, 1991b.
48. WILLIAMS, K., DICHTER, M. A., AND MOLINOFF, P. B.: Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. Mol. Pharmacol. 42: 147-151, 1993a.
49. WILLIAMS, K., RUSSELL S. L, SHEN, Y. M. AND MOLINOFF, P. B.: Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron 10: 267-278, 1993b.
50. WILLIAMS, K., ZAPPIA, A. M., PRITCHETT, D. P., SHEN, Y. M. AND MOLINOFF, P. B.: Differential actions of polyamines at recombinant NMDA receptors. Mol. Pharmacol. 45: 803-809, 1994.
51. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J. Neurochem. 50: 274-281, 1988.
52. YAMAMOTO, H., YAMAMOTO, T., SAGI, N., KLENEROVA, V., GOJI, K, KAWAI, N., BABA, A., TAKAMORI, E. AND MOHOJI, T.: Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site. J. Neurosci. 15: 731-736, 1995.
53. ZHONG, J., CARROZZA, D. P., WILLIAMS, K., PRITCHETT, D. B. AND MOLINOFF, P. B.: Expression of mRNA's encoding subunits of the NMDA receptor in developing rat brain. J. Neurochem. 84: 531-539, 1995.